News & Events

Domenick Bertelli Chairs Biopharma Digital Adoption Panel at the MIT Sloan Healthcare and BioInnovations Conference

|
Conference Events

Domenick chaired the Biopharma Digital Adoption Panel at the 17th Annual MIT Sloan Healthcare and BioInnovations Conference (SHBC).  The Panel focused on exploring how the life sciences industry is adopting new technologies and approaches enabled by digital advances across the biopharma value chain, from Discovery to the clinic to the marketplace.  The discussion covered topics including:

  • How AI and next-generation lab equipment are reshaping drug discovery and identification of biomarkers
  • How digital technologies are enabling new approaches to clinical trial design (stratification, end points), patient recruitment, outcome analysis, and post-trial follow-up
  • How new digital platforms are enabling more effective outreach to patients and physicians

Panelists included:

  • Rob Goodwin, Vice President and Head of Global Product Development Operations Center of Excellence, Pfizer
  • Jeremy Jenkins, PhD, Executive Director and Head of Data Science in Chemical Biology & Therapeutics, Novartis Institutes for BioMedical Research
  • Eduardo Cornejo, ITS Digital Innovation Market Lead, Sanofi
  • Jennifer Staffin, Automation Solutions Leader, GE Healthcare Life Sciences
  • Noam Kirson, PhD, Managing Principal, Analysis Group

The MIT Sloan Healthcare and BioInnovations Conference brings together industry, academic and policy leaders to discuss the most pressing issues and exciting innovations in the healthcare sector. The theme of this year’s conference was “Frontiers in the Digital Era: Decoding the Future of Healthcare”.  Putnam was proud to once again be a sponsor and co-organizer of the SHBC conference.

Strategy for the Life Sciences